COVID-19 is a new disease in the history of mankind, but the neurotropic properties of the causative agent of this disease SARS-CoV-2 are already beyond doubt. It is well known that some neurotropic viruses can cause nervous system disease several years after infection, and perhaps this also applies to coronavirus infection. Given the pandemic situation, this could have serious consequences in the form of an increase in the number of patients with neurological disorders in the future. The method of immunochemical analysis ELI-Neuro-Test, developed by Professor A.B. Poletaev, makes it possible to comprehensively assess the state of neurotransmitter systems and, long before the appearance of neurological symptoms, with a high probability of predicting diseases of the central nervous system, in particular those associated with COVID-19. Using this method, an individual profile of serum immunoreactivity is analyzed, depending on changes in the relative content of IgG autoantibodies directed to 12 autogens of the nervous system. In our small study, we identified in patients who underwent COVID-19 immunochemical signs of damage to the GABAergic (58.6%), opioid (37.9%), serotonergic (20.7%), cholinergic (13.8%) neurotransmitter systems, and also markers of axonal damage (20.7%), demyelination (10.3%) and reactive astrogliosis (24.1%), which suggest what variety of neurological deficits can be expected in the medium and long-term in patients with SARS-CoV-2 infection.
| Mualliflar | Иноятова Фируза Хидоятовна, Рахматуллаева Гулнора Қутбиддиновна, Вахобова Нигина Анорбековна, Миркомилов Элдор Миркодир угли, Салиходжаева Умида Шакировна |
|---|---|
| Jurnal | Журнал неврологии и нейрохирургических исследований / Journal of Neurology and Neurosurgical Research |
| Nashr sanasi | 2022-02-26 |
| Jild | 3 |
| Son | 1 |
| Til | Rus |
COVID-19, нервная система, нейротропные аутоантитела, ранняя диагностика, COVID-19, nervous system, neurotropic autoantibodies, early diagnosis, COVID-19, асаб тизими, нейротроп аутоантитаналар, эрта ташхислаш
One of the severe complications of COVID-19 is ischemic stroke, which have tendency to occurring not only during the diseases, but even after recovery from COVID-19. Because of post-COVID syndrome, procoagulant and…
To achieve the set goals, the "Register of cerebral strokes" of the Khorezm region for 2019 was carried out. As a result, it was revealed that ischemic strokes (IS) and hemorrhagic strokes (HS) prevailed in the winter…
In the context of COVID-19, cerebral venous thrombosis has proven to be a relatively common complication. The presence of venous strokes is an independent risk factor for poor prognosis in patients with severe COVID-19…
At the present stage, epilepsy refers to neuropsychiatric diseases, which, according to the WHO definition, require considerable attention, since the frequency of this disease tends to increase every year. The paper…
The article presents the results of the open longitudinal study of two parallel groups in which the effect of the Lavien on the clinical course of acute ischemic stroke and it’s secondary hemodynamic effects were…
Cerebrovascular diseases are one of the most serious medical and social problems in the modern world. According to WHO data for 2013, about 6.2 million people worldwide die annually from stroke or other forms of…
A clinical examination of adolescents who underwent COVID-19 infection revealed the presence of post-COVID syndrome: frequent frequent acute respiratory infections and tonsillitis in the next 6 months, fatigue and…
The urgency of the problem. Multiple sclerosis (MS) is the most common chronic inflammatory disease of the central nervous system (CNS), affecting more than 3…
The article is devoted to the modern tactics of epilepsy management during pregnancy. Based on literature data and their own extensive experience, the authors have developed and successfully implemented a scheme for…
The article presents a modern classification of back pain and differentiated management tactics for patients with various types of dorsalgia. The tactics of management and preference for the choice of drugs…